LRP11在肝细胞癌中的表达与临床病理参数及预后关系的研究

Journal: Basic Medical Theory Research DOI: 10.12238/bmtr.v8i1.18579

李自莲, 王燕, 王天云, 欧志燕, 苏敏, 郭敏敏, 何青晏, 赵春梅, 奎翔

昆明医科大学第二附属医院病理科

Abstract

目的：研究低密度脂蛋白受体相关蛋白11(low density lipoprotein receptor-related protein 11,

Keywords

低密度脂蛋白受体相关蛋白11；肝细胞癌；临床病理参数；预后

Full Text

PDF - Viewed/Downloaded: 0 Times

References

[1] Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel,Lindsey A Torre, Ahmedin Jemal.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortal
[2] Global cancer burden growing, amidst mounting need for services[J].Saudi Med J,2024,45(3):326-327.
[3] Han BF,Zheng RS, Zeng HM, et al. Cancer incidence and mortality in China,2022[J].Journal of the National Cancer Cen
[4] Previn Ganesan, Laura M Kulik.Hepatocellular Carcino
[5] Tony Dazhong Huang,Jason Behary,Amany Zekry.Non-
[6] 王颖.LRP11在宫颈癌发生发展中的作用及机制研究[D].山东:山东大学,2019.
[7] Herz J, Strickland DK. LRP: a multifunctional scavenger and signaling receptor[J].Clin. Invest,2002,108(6):779-784.
[8] Ju W,Zheng R,Zhang S,et al. Cancer statistics in Chinese older people,2022:current burden, time trends,and compariso
[9] Gan S, Ye J, Li J, et al. LRP11 activates β-catenin to induce PD-L1 expression in prostate cancer[J]. J Drug Target, 2020,28(5):508-515.

Citing this article:

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License